LM
AHCO icon

Luminus Management’s AdaptHealth AHCO Stock Holding History

Luminus Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,147
Closed -$347K – 27
2024
Q1 		$347K Buy
+30,147
New +$256K 0.16% 23

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Luminus Management's AHCO Position: Q2 2024 in Review

Luminus Management sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 30,147 shares — an estimated $347K sold.

Luminus Management first reported a position in AHCO in Q1 2024 and held it in 1 quarter. The position peaked at $347K in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Luminus Management reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Luminus Management sold 30,147 AdaptHealth shares in Q2 2024, an estimated $347K.
  • Luminus Management first reported a position in AdaptHealth in Q1 2024 and held it in 1 quarter.
  • Luminus Management's AdaptHealth position peaked at $347K in Q1 2024.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Luminus Management's 13F filing for Q2 2024, filed 14 Aug 2024.